In a post on X.com, Neuralink said it had been granted regulatory approval for "a new feasibility trial to extend BCI control ...

Erin Taylor, a disability advocate and botany enthusiast with ALS, used the technology to introduce herself and then welcome ...

Biotech firm GeneCode joins the European Innovation Council's Scaling Club, advancing its mission to tackle neurodegenerative ...

Celosia Therapeutics is hoping to use gene therapy to treat neurodegenerative diseases such as Motor Neurone Disease (MND).

Study failed to meet primary and secondary efficacy endpoints - WARREN, N.J., Nov. 26, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced ...

We recently published a list of 10 Cheapest Stocks to Buy On Robinhood. In this article, we are going to take a look at where ...

Since Jimmer Szatkowski opened Upstate New York’s first Chick-fil-A in 2018, he’s been at the restaurant most every day. He’s ...

LYON, France I6, 2024 I MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of ...

Explore some of the most influential disabled names in history and discover how they overcame adversity to change the world ...

Specializing in neurotechnologies, the American startup Neuralink has already made a name for itself by implanting a chip in ...

PTC Therapeutics’ phase 2 CardinALS study of utreloxastat in ALS patients fails to meet primary endpoint: Warren, New Jersey Thursday, November 28, 2024, 15:00 Hrs [IST] PTC The ...

Thompson, who has spent the latter part of his coaching career battling ALS, is more than a great football coach. He is a ...